Stock Events

Ad Pepper Media Intl Nv 

€1.76
15
-€0.02-1.12% Thursday 15:30

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
37.98M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Dividends

0%Dividend Yield
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

19NovExpected
Q3 2022
Q4 2022
Q2 2023
Q3 2023
Q1 2024
Q2 2024
Next
-2.53
-1.69
-0.85
-0.01
Expected EPS
N/A
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow APM.XETRA. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Gilead Sciences
GILD
Mkt Cap98.35B
Gilead Sciences focuses on infectious diseases, a key area for Aptorum, making them direct competitors in developing treatments.
Merck
MRK
Mkt Cap300.25B
Merck operates in various therapeutic areas including infectious diseases, competing with Aptorum's research and development focus.
Pfizer
PFE
Mkt Cap164.39B
Pfizer has a broad portfolio including anti-infectives, directly competing with Aptorum's infectious disease projects.
Abbvie
ABBV
Mkt Cap346.75B
AbbVie, with its research in diverse therapeutic areas, competes with Aptorum, especially in the infectious disease sector.
Novartis
NVS
Mkt Cap244.75B
Novartis competes across multiple therapeutic areas, including those targeted by Aptorum, making them a key competitor.
Astrazeneca
AZN
Mkt Cap271.67B
AstraZeneca has a strong focus on innovation in healthcare, including infectious diseases, positioning them as competitors to Aptorum.
Bristol-Myers Squibb
BMY
Mkt Cap101.27B
Bristol Myers Squibb's diverse biopharmaceutical products compete with Aptorum's therapeutic development efforts.
AMGEN
AMGN
Mkt Cap179.38B
Amgen's broad focus on biotechnological medicines puts them in competition with Aptorum's diverse therapeutic pipeline.
Regeneron Pharmaceuticals
REGN
Mkt Cap130.59B
Regeneron Pharmaceuticals, known for its innovative treatments, competes with Aptorum in developing novel therapies.
Vertex Pharmaceuticals
VRTX
Mkt Cap127.99B
Vertex Pharmaceuticals' focus on creating transformative medicines for serious diseases competes with Aptorum's mission and pipeline.

About

ad pepper media International N.V., an investment holding company, engages in the development of performance marketing solutions worldwide. It operates through three segments: ad pepper, ad agents, and Webgains. The ad pepper segment operates iLead, a lead generation platform, that helps in acquisition of client data free from financial risk; iSense, a targeting platform, that helps in delivering the right message to the right person in the right place at the right time; Mailpepper, an email marketing platform; and provides performance display online advertising solution. The ad agents segment is involved in the search engine advertising and optimization, affiliate management, product data management, social media advertising, analytics and data, banner and video advertising material, Google marketing platform, display advertising, and consulting activities. The Webgains segment designs campaigns; and provides affiliate marketing solutions. The company was founded in 1999 and is headquartered in Nuremberg, Germany.
Show more...
CEO
Dr. Jens Korner
Employees
207
Country
NL
ISIN
NL0000238145
WKN
000940883

Listings